tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Alpine Immune Sciences (ALPN)
:ALPN
US Market
ALPN
Alpine Immune Sciences
Overview
Dividends
Statistics
New
Historical Prices
New
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Alpine Immune Sciences (ALPN) Price & Analysis

Compare
― Followers

ALPN Stock Chart & Stats

Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Alpine Immune Sciences News

ALPN Upcoming Earnings Report: What to Expect?
ALPN Upcoming Earnings Report: What to Expect?
Alpine Immune Sciences (ALPN) is scheduled to report 2nd quarter earnings on 08/13/2024. Regarding Q2 estimates, Wall Street...
12M ago
ALPN
Alpine Immune Sciences Communicates Key Updates Regularly
Alpine Immune Sciences Communicates Key Updates Regularly
The latest announcement is out from Alpine Immune Sciences Inc (ALPN). Alpine Immune Sciences actively shares vital updates...
1y ago
8K
ALPN
Alpine Immune Sciences reports Q1 EPS (28c), consensus (41c)
Alpine Immune Sciences reports Q1 EPS (28c), consensus (41c)
As of March 31, 2024, Alpine’s cash and investments totaled $362.4 million compared to $368.2 million as of...
1y ago
ALPN
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Alpine Immune Sciences (ALPN)...
1y ago
CPG
LAC
Alpine Immune Sciences downgraded to Hold from Buy at TD Cowen
Alpine Immune Sciences downgraded to Hold from Buy at TD Cowen
TD Cowen downgraded Alpine Immune Sciences (ALPN) to Hold from Buy without a price target after the company...
1y ago
ALPN
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
Novartis (NVS) presented results from a pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study of Fabhalta, an...
1y ago
NVS
ALPN
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...
1y ago
ADIL
ALPN
Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
Alpine Immune Sciences downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Alpine Immune Sciences (ALPN) to Market Perform from Outperform with a price target of $65, up...
1y ago
ALPN
VRTX
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
Shares of this drugmaker are on the rise after Alpine Immune Sciences (ALPN), whose lead candidate is similar...
1y ago
ALPN
VERA
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here...
1y ago
V
IT
Wedbush downgrades Alpine Immune, sees takeout deal closing
Wedbush downgrades Alpine Immune, sees takeout deal closing
Wedbush analyst Robert Driscoll downgraded Alpine Immune Sciences (ALPN) to Neutral from Outperform with a price target of...
1y ago
ALPN
Alpine Immune Sciences downgraded to Neutral from Buy at H.C. Wainwright
Alpine Immune Sciences downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Alpine Immune Sciences to Neutral from Buy with a $65 price target after the company...
1y ago
ALPN
M&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
M&A: Vertex Bolsters its Drug Portfolio with Alpine Deal
Vertex Pharmaceuticals (NASDAQ:VRTX) has entered into an all-cash deal worth $4.9 billion to acquire Alpine Immune Sciences (NASDAQ:ALPN)....
1y ago
ALPN
VRTX
Alpine Immune Sciences Announces New Chief Accounting Officer
Alpine Immune Sciences Announces New Chief Accounting Officer
An update from Alpine Immune Sciences Inc (ALPN) is now available. Alpine Immune Sciences, Inc. has appointed U....
1y ago
8K
ALPN

ALPN FAQ

What was Alpine Immune Sciences’s price range in the past 12 months?
Currently, no data Available
What is Alpine Immune Sciences’s market cap?
Currently, no data Available
When is Alpine Immune Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alpine Immune Sciences’s earnings last quarter?
Currently, no data Available
Is Alpine Immune Sciences overvalued?
According to Wall Street analysts Alpine Immune Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Alpine Immune Sciences pay dividends?
    Alpine Immune Sciences does not currently pay dividends.
    What is Alpine Immune Sciences’s EPS estimate?
    Alpine Immune Sciences’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Alpine Immune Sciences have?
    Currently, no data Available
    What happened to Alpine Immune Sciences’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Alpine Immune Sciences?
    Currently, no hedge funds are holding shares in ALPN

    Alpine Immune Sciences (ALPN) Earnings & Revenues

    Currently, no data available
    Please return soon. This page is being updated.
    Historic Earnings Reports

    Ownership Overview

    1.88%98.12%
    ―
    Insiders
    1.88%
    Mutual Funds
    ― Other Institutional Investors
    98.12% Public Companies and
    Individual Investors
    Detailed Ownership Overview >

    Options Prices

    Currently, No data available
    ---
    Popular Stocks

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing